Moving to Cost effective locations- A unique shift

Moving to Cost effective locations- A unique shift

Moving to cost effective locations is an effort by almost all major pharma companies in the last 6-8 months particularly in the areas of drug manufacturing . One of the key locations today in manufacturing is the Asia Pacific region particularly the Indian geography. Companies like GSK and Pfizer have already moved their manufacturing capacities to India. One of the recent examples is Eisai, a leading Japanese pharma drug maker which has taken the bold step to manufacture Aricept Alzheimer's drug in India for exports to Japan, the United States and Europe as early as 2011. Eisai will start producing the drug at a newly constructed plant in the Indian state of Andhra Pradesh. Aricept accounts for about 40 percent of Eisai's total sales. Eisai is also expected to begin Indian production of the ulcer treatment Pariet, which will go off-patent in the United States in 2013.


Source:
http://blogs.veedacr.com/Lists/Categories/Category.aspx?Name=Industry%20Trends%20